Dapagliflozin, an SGLT2 inhibitor, ameliorates acetic acid-induced colitis in rats by targeting NFκB/AMPK/NLRP3 axis
Magdy Abou El-Rous, Sameh Saber, Eman M. Raafat, Amany A.E. Ahmed
Topics & Concepts
InflammasomePharmacologyInflammationMedicineApoptosisColitisPyroptosisCaspase 1Inflammatory bowel diseaseImmunologyChemistryInternal medicineDiseaseBiochemistryInflammasome and immune disordersNF-κB Signaling PathwaysIL-33, ST2, and ILC Pathways